WLLW Stock Overview
A biotechnology company, develops, produces, and sells plant derived ingredients for consumer care, food and beverage, and pharmaceutical products in the United States. More details
| Snowflake Score | |
|---|---|
| Valuation | 2/6 |
| Future Growth | 0/6 |
| Past Performance | 0/6 |
| Financial Health | 4/6 |
| Dividends | 0/6 |
My Notes
Capture your thoughts, links and company narrative
Willow Biosciences Inc. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | CA$0.025 |
| 52 Week High | CA$0.14 |
| 52 Week Low | CA$0.02 |
| Beta | 1.18 |
| 1 Month Change | -61.54% |
| 3 Month Change | -72.22% |
| 1 Year Change | -75.00% |
| 3 Year Change | -93.59% |
| 5 Year Change | -96.58% |
| Change since IPO | -99.17% |
Recent News & Updates
Recent updates
Is Willow Biosciences (TSE:WLLW) In A Good Position To Deliver On Growth Plans?
Apr 11
We Think Willow Biosciences (TSE:WLLW) Needs To Drive Business Growth Carefully
Dec 20We Think Willow Biosciences (TSE:WLLW) Can Afford To Drive Business Growth
Sep 02We Think Willow Biosciences (TSE:WLLW) Can Easily Afford To Drive Business Growth
May 20Calculating The Fair Value Of Willow Biosciences Inc. (TSE:WLLW)
Jan 19Shareholder Returns
| WLLW | CA Biotechs | CA Market | |
|---|---|---|---|
| 7D | -16.7% | 0.1% | -0.5% |
| 1Y | -75.0% | 10.7% | 17.7% |
Return vs Industry: WLLW underperformed the Canadian Biotechs industry which returned 10.4% over the past year.
Return vs Market: WLLW underperformed the Canadian Market which returned 17.9% over the past year.
Price Volatility
| WLLW volatility | |
|---|---|
| WLLW Average Weekly Movement | 22.9% |
| Biotechs Industry Average Movement | 12.5% |
| Market Average Movement | 8.4% |
| 10% most volatile stocks in CA Market | 18.3% |
| 10% least volatile stocks in CA Market | 2.9% |
Stable Share Price: WLLW's share price has been volatile over the past 3 months compared to the Canadian market.
Volatility Over Time: WLLW's weekly volatility has increased from 16% to 23% over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 2019 | 19 | Chris Savile | www.willowbio.com |
Willow Biosciences Inc., a biotechnology company, develops, produces, and sells plant derived ingredients for consumer care, food and beverage, and pharmaceutical products in the United States. The company has a collaboration agreement with SUANFARMA to develop anti-infective API through precision fermentation; and a multi-product development and licensing partnership with Laurus Labs for manufacturing active pharmaceutical ingredients. Willow Biosciences Inc. was founded in 2019 and is headquartered in Calgary, Canada.
Willow Biosciences Inc. Fundamentals Summary
| WLLW fundamental statistics | |
|---|---|
| Market cap | CA$3.61m |
| Earnings (TTM) | -CA$7.71m |
| Revenue (TTM) | CA$2.87m |
1.3x
P/S Ratio-0.5x
P/E RatioIs WLLW overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| WLLW income statement (TTM) | |
|---|---|
| Revenue | CA$2.87m |
| Cost of Revenue | CA$4.94m |
| Gross Profit | -CA$2.07m |
| Other Expenses | CA$5.65m |
| Earnings | -CA$7.71m |
Last Reported Earnings
Sep 30, 2024
Next Earnings Date
n/a
| Earnings per share (EPS) | -0.054 |
| Gross Margin | -72.15% |
| Net Profit Margin | -268.91% |
| Debt/Equity Ratio | 361.0% |
How did WLLW perform over the long term?
See historical performance and comparisonCompany Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2025/01/31 06:40 |
| End of Day Share Price | 2025/01/31 00:00 |
| Earnings | 2024/09/30 |
| Annual Earnings | 2023/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .
Analyst Sources
Willow Biosciences Inc. is covered by 1 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| David Kideckel | ATB Capital Markets |